EmoGen, Inc. is an independent research and development company pursuing federally supported research in kinetic energy recapture and motion-native energy architecture.
Research inquiryIndustrial and transportation systems discard 60 to 95 percent of their fuel energy before useful work is performed. EmoGen is developing architecture to intercept that loss in the window between kinetic dispersal and thermal equilibrium, before it completes its transition to unrecoverable heat.
Rather than converting kinetic energy to electricity at the first opportunity, motion-native design retains energy in the kinetic domain as long as possible, reducing conversion penalties and improving system-level efficiency across industrial, transportation, and distributed power applications.
The goal is not to replace electricity. It is to recover the motion we are currently throwing away before it disperses into heat.
Baseline characterization — PZT / PVDF materials platform
Bench-scale demonstration of kinetic retention efficiency using commercial piezoelectric materials. Establishes the empirical baseline for comparison at subsequent phases.
Advanced platform prototype — Graphene / MoS₂ / Molybdenum alloy
Next-generation nanomaterial architecture targeting a minimum 2x improvement in kinetic retention efficiency over the Phase I baseline, with programmable output channel characterization.
Scalable application modeling and Tier 3 feasibility
Computational modeling across industrial deployment contexts. Feasibility study for phononic metamaterial lattice architecture targeting 70 to 90 percent kinetic retention efficiency.
Dr. Paul Page
Founder & Principal Investigator, EmoGen, Inc.
Independent researcher working at the intersection of kinetic energy systems, materials science, and motion-native architecture. EmoGen, Inc. is pursuing federally supported research through DOE concept proposal channels, with a research program documented across a tiered materials platform from commercially available piezoelectric composites through advanced nanomaterial architectures.
EmoGen, Inc. welcomes inquiries from research institutions, federal program offices, and qualified industry partners.